Skip to main content

Table 2 Association between methylation risk scores and atherosclerosis measures in GENOA African-Americans

From: Epigenetics of single-site and multi-site atherosclerosis in African Americans from the Genetic Epidemiology Network of Arteriopathy (GENOA)

Outcome

Methylation risk score

Model 1

Model 2

Model 3

Beta

SE

P

Beta

SE

P

Beta

SE

P

Coronary artery calcification score (CAC)a

MRSCAC

0.262

0.146

0.074

0.153

0.173

0.295

0.138

0.139

0.318

MRScarotid

0.700

0.155

8.66 × 10–6

0.425

0.199

0.033

0.411

0.191

0.032

Abdominal aorta calcification score (AAC)a

MRSCAC

0.364

0.160

0.023

0.175

0.154

0.258

0.173

0.151

0.252

MRScarotid

1.046

0.167

1.10 × 10–9

0.580

0.211

0.006

0.605

0.208

0.004

Ankle–brachial index (ABI)

MRSCAC

0.013

0.006

0.025

0.015

0.006

0.008

0.016

0.006

0.006

MRScarotid

− 0.014

0.006

0.021

− 0.009

0.008

0.275

− 0.007

0.008

0.400

Multi-site atherosclerosis score

MRSCAC

0.317

0.170

0.064

0.145

0.165

0.382

0.127

0.162

0.433

MRScarotid

1.165

0.177

1.65 × 10–10

0.718

0.225

0.002

0.691

0.223

0.002

  1. Model 1 is adjusted for age, sex, time between measures, and the first 4 genetic principal components
  2. Model 2 is adjusted for Model 1 covariates and smoking status
  3. Model 3 is adjusted for Model 2 covariates, hypertension status, diabetes status, body mass index, and total cholesterol levels adjusted for statin use
  4. Beta is the change in the atherosclerosis measure associated with a 1 unit increase in the MRS
  5. P values significant after Bonferroni correction (P < 0.025) are shown in bold font
  6. aCoronary artery and abdominal aorta calcification scores were transformed as ln[(CAC + 1)] and ln[(AAC + 1)]